A made-in-Canada vaccine to protect against COVID-19 began human clinical trials Tuesday in Toronto, says the biotechnology company that developed the vaccine. Brad Sorenson, the company's CEO, said it's the first time a vaccine designed and manufactured in Canada has begun clinical trials. Quebec-based pharmaceutical Medicago began clinical trials last July of its coronavirus vaccine that is based on another technology. The company says it is the first fully made-in-Canada coronavirus vaccine to reach clinical trials in this country. Currently, Canada lacks the capacity to manufacture the millions of doses of coronavirus vaccines needed to immunize people outside of a clinical trial setting.

Source: CBC News January 26, 2021 13:00 UTC